Paroxetine overdose

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

## Contents

* 1 Overdosage topics
* 1.1 Human experience
* 1.1.1 Reported cases
* 1.1.2 Adverse events
* 1.2 Overdosage management

## Overdosage topics

[edit | edit source]

Human experience

* Reported cases
* Adverse events

Overdosage management

* * *

### Human experience

[edit | edit source]

#### Reported cases

[edit | edit source]

Since the introduction of Paroxetine hydrochloride in the United States, 342 spontaneous cases of deliberate or accidental overdosage during Paroxetine treatment have been reported worldwide (circa 1999). These include overdoses with Paroxetine alone and in combination with other substances. Of these, 48 cases were fatal and of the fatalities, 17 appeared to involve Paroxetine alone. Eight fatal cases that documented the amount of Paroxetine ingested were generally confounded by the ingestion of other drugs or alcohol or the presence of significant comorbid conditions. Of 145 non-fatal cases with known outcome, most recovered without sequelae. The largest known ingestion involved 2,000 mg of Paroxetine (33 times the maximum recommended daily dose) in a patient who recovered. Return to top

#### Adverse events

[edit | edit source]

Commonly reported adverse events associated with Paroxetine overdosage include somnolence, coma, nausea, tremor, tachycardia, confusion, vomiting, and dizziness. Other notable signs and symptoms observed with overdoses involving Paroxetine (alone or with other substances) include mydriasis, convulsions (including status epilepticus), ventricular dysrhythmias (including torsade de pointes), hypertension, aggressive reactions, syncope, hypotension, stupor, bradycardia, dystonia, rhabdomyolysis, symptoms of hepatic dysfunction (including hepatic failure, hepatic necrosis, jaundice, hepatitis, and hepatic steatosis), serotonin syndrome, manic reactions, myoclonus, acute renal failure, and urinary retention. Return to top

### Overdosage management

[edit | edit source]

Treatment should consist of those general measures employed in the management of overdosage with any drugs effective in the treatment of major depressive disorder.
Ensure an adequate airway, oxygenation, and ventilation. Monitor cardiac rhythm and vital signs. General supportive and symptomatic measures are also recommended. Induction of emesis is not recommended. Gastric lavage with a large-bore orogastric tube with appropriate airway protection, if needed, may be indicated if performed soon after ingestion, or in symptomatic patients.
Activated charcoal should be administered. Due to the large volume of distribution of this drug, forced diuresis, dialysis, hemoperfusion and exchange transfusion are unlikely to be of benefit. No specific antidotes for Paroxetine are known.
A specific caution involves patients who are taking or have recently taken Paroxetine who might ingest excessive quantities of a tricyclic antidepressant. In such a case, accumulation of the parent tricyclic and/or an active metabolite may increase the possibility of clinically significant sequelae and extend the time needed for close medical observation (see PRECAUTIONS, Drugs Metabolized by CYP2D6).
In managing overdosage, consider the possibility of multiple drug involvement. The physician should consider contacting a poison control center for additional information on the treatment of any overdose. Telephone numbers for certified poison control centers are listed in the Physicians’ Desk Reference (PDR). Return to top

* * *

Adapted from the FDA Package Insert.